Breast-conserving therapy for breast cancer;Le traitement chirurgical conservateur du cancer du sein

Cancer/Radiotherapie

Volumn 8, Issue 1, 2004, Pages 21-28

  Doridot, V ^a   Nos, C ^a   Aucouturier, J S ^a   Sigal Zafrani, B ^a   Fourquet, A ^a   Clough, K B ^a  

^a INSTITUT CURIE   (France)

Author keywords

Breast cancer; Breast conserving treatment; Oncoplastic surgery

Indexed keywords

ANTINEOPLASTIC AGENT; TAMOXIFEN;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER SIZE; CANCER SURGERY; CONSERVATIVE TREATMENT; HUMAN; INFLAMMATION; MAMMOGRAPHY; MINIMALLY INVASIVE SURGERY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; STANDARD; SURGICAL TECHNIQUE; TREATMENT INDICATION;

EID: 1242338232     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2003.10.008     Document Type: Short Survey

References (67)

1. Arnesson L.G., Smeds S., Fagerberg G., Grontoft O. Follow-up of two treatment modalities for ductal cancer in situ of the breast. Br J Surg. 76:1989;672-675.
2. Badgwell B.D., Povoski S.P., Abdessalam S.F., Young D.C., Farrar W.B., Walker M.J., et al. Patterns of recurrence after sentinel lymph node biopsy for breast cancer. Ann Surg Oncol. 10:2003;376-380.
3. Bartelink H., Borger J.H., van Dongen J.A., Peterse J.L. The impact of tumor size and histology on local control after breast-conserving therapy. Int J Radiat Oncol Biol Phys. 19:1990;833-842.
4. Bartelink H., Horiot J.C., Poortmans P., Struikmans H., Van den Bogaert W., Barillot I., et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med. 345:2001;1378-1387.
5. Bloom K.J., Dowlat K., Assad L. Pathologic changes after interstitial laser therapy of infiltrating breast carcinoma. Am J Surg. 182:2001;384-388.
6. Bobin J.Y., Zinzindohoue C., Isaac S., Saadat M., Roy P. Tagging sentinel lymph nodes: a study of 100 patients with breast cancer. Eur J Cancer. 35:1999;569-573.
7. Borger J., Kemperman H., Hart A., Peterse H., van Dongen J., Bartelink H. Risk factors in breast-conservation therapy. J Clin Oncol. 12:1994;653-660.
8. Boyages J., Recht A., Connolly J.L., Schnitt S.J., Gelman R., Kooy H., et al. Early breast cancer: predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. Radiother Oncol. 19:1990;29-41.
9. Bussieres E., Guyon F., Thomas L., Stockle E., Faucher A., Durand M. Conservation treatment in subareolar breast cancers. Eur J Surg Oncol. 22:1996;267-270.
10. Cheng L., Al-Kaisi N.K., Gordon N.H., Liu A.Y., Gebrail F., Shenk R.R. Relationship between the size and margin status of ductal carcinoma in situ of the breast and residual disease. J Natl Cancer Inst. 89:1997;1356-1360.
11. Chung M.A., Steinhoff M.M., Cady B. Clinical axillary recurrence in breast cancer patients after a negative sentinel node biopsy. Am J Surg. 184:2002;310-314.
12. Clarke D.H., Martinez A.A. Identification of patients who are at high risk for locoregional breast cancer recurrence after conservative surgery and radiotherapy: a review article for surgeons, pathologists, and radiation and medical oncologists. J Clin Oncol. 10:1992;474-483.
13. Clough K.B., Nos C., Salmon R.J., Soussaline M., Durand J.C. Conservative treatment of breast cancers by mammaplasty and irradiation: a new approach to lower quadrant tumors. Plast Reconstr Surg. 96:1995;363-370.
14. Clough K.B., Lewis J.S., Couturaud B., Fitoussi A., Nos C., Falcou M.C. Oncoplastic techniques allow extensive resections for breast-conserving therapy of breast carcinomas. Ann Surg. 237:2003;26-34.
15. Cowen D., Houvenaeghel G., Jacquemier J., Resbeut M., Largillier R., Bardou V.J., et al. Local recurrences after conservative treatment of breast cancer: risk factors and influence on survival. Cancer Radiother. 2:1998;460-468.
16. Faverly D., Burgers L., Bult P., Holland R. Three dimentional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol. 11:1994;193-198.
17. Fisher B., Redmond C. Lumpectomy for breast cancer: an update of the NSABP experience. J Natl Cancer Inst Monogr. 1992;7-13. National Surgical Adjuvant Breast and Bowel Project.
18. Fisher B., Anderson S., Redmond C.K., Wolmark N., Wickerham D.L., Cronin W.M. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 333:1995;1456-1461.
19. Fisher E.R., Anderson S., Redmond C., Fisher B. Pathologic findings from the National Surgical Adjuvant Breast Project protocol B-06. 10-year pathologic and clinical prognostic discriminants. Cancer. 71:1993;2507-2514.
20. Fisher E.R., Costantino J., Fisher B., Palekar A.S., Redmond C., Mamounas E. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). Cancer. 75:1995;1310-1319. The National Surgical Adjuvant Breast and Bowel Project Collaborating Investigators.
21. Fourquet A., Campana F., Zafrani B., Mosseri V., Vielh P., Durand J.C., et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys. 17:1989;719-725.
22. Fourquet A., Sigal-Zafrani B., Clough K.B. Breast conserving surgery plus radiation therapy in DCIS: The Institut Curie Experience. 2nd ed Silverstein M.J. Ductal Carcinoma In Situ of the breast. 2002;539-544 Lippincott Williams&Wilkins, Philadelphia.
23. Fowble B., Solin L.J., Schultz D.J., Rubenstein J., Goodman R.L. Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications of treatment. Radiother Oncol. 11:1988;297-303.
24. Gage I., Schnitt S.J., Nixon A.J., Silver B., Recht A., Troyan S.L., et al. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer. 78:1996;1921-1928.
25. Giuliano A.E., Kirgan D.M., Guenther J.M., Morton D.L. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 220:1994;391-398.
26. Goldstein N.S., Kestin L., Vicini F. Pathologic features of initial biopsy specimens associated with residual intraductal carcinoma on reexcision in patients with ductal carcinoma in situ of the breast referred for breast-conserving therapy. Am J Surg Pathol. 23:1999;1340-1348.
27. Haffty B.G., Wilson L.D., Smith R., Fischer D., Beinfield M., Ward B., McKhann C. Subareolar breast cancer: long-term results with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 33:1995;53-57.
28. Holland R., Veling S.H., Mravunac M., Hendriks J.H. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer. 56:1985;979-990.
29. Holland R., Connolly J.L., Gelman R., Mravunac M., Hendriks J.H., Verbeek A.L., et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol. 8:1990;113-118.
30. Holland P., Gandhi A., Knox W., Wilson M., Baildam A., Bundred N. The importance of complete excision in the prevention of local recurrence of ductal carcinoma in situ. Br J Cancer. 77:1998;110-114.
31. Hynynen K., Pomeroy O., Smith D.N., Huber P.E., McDannold N.J., Kettenbach J., et al. MR imaging-guided focused ultrasound surgery of fibroadenomas in the breast: a feasibility study. Radiology. 219:2001;176-185.
32. Izzo F., Thomas R., Delrio P., Rinaldo M., et al. Radiofrequency ablation in patients with primary breast carcinoma: a pilot study in 26 patients. Cancer. 92:2001;2036-2044.
33. Jacobson J.A., Danforth D.N., Cowan K.H., d'Angelo T., Steinberg S.M., Pierce L., et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med. 332:1995;907-911.
34. Kestin L.L., Goldstein N.S., Lacerna M.D., Balasubramaniam M., Martinez A.A., Rebner M., et al. Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy. Cancer. 88:2000;596-607.
35. Krag D., Weaver D., Ashikaga T., Moffat F., Klimberg V.S., Shriver C., Feldman S., Kusminsky R., Gadd M., Kuhn J., Harlow S., Beitsch P. The sentinel node in breast cancer - a multicenter validation study. N Engl J Med. 339:1998;941-946.
36. Kurtz J.M. Factors which predict breast relapse. Recent Results Cancer Res. 127:1993;137-150.
37. Lee A.K., DeLellis R.A., Silverman M.L., Heatley G.J., Wolfe H.J. Prognostic significance of peritumoral lymphatic and blood vessel invasion in node-negative carcinoma of the breast. J Clin Oncol. 8:1990;1457-1465.
38. Lifrange E., Colin C. Supraconservative breast surgery. J Gynecol Obstet Biol Reprod. 29:2000;285-287.
39. Mauriac L., Durand M., Floquet A., Tchen N., Bonichon F. First line tamoxifen for invasive hormonal sensitive non metastatic breast carcinomas in young postmenopausal patients. Breast Cancer Res Treat. 57:1999;435.
40. Mauriac L., MacGrogan G., Avril A., Durand M., Floquet A., Debled M., et al. Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Ann Oncol. 10:1999;47-52. Institut Bergonie Bordeaux Groupe Sein (IBBGS).
41. Marti W.R., Zuber M., Oertli D., Weber W.P., Muller D., Kochli O.R., et al. Advanced breast biopsy instrumentation for the evaluation of impalpable lesions: a reliable diagnostic tool with little therapeutic potential. Eur J Surg. 167:2001;15-18.
42. Meric F., Mirza N.Q., Vlastos G., Buchholz T.A., Kuerer H.M., Babiera G.V., et al. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer. 97:2003;926-933.
43. Multon O., Bourgeois D., Validire P., Vilcoq J.R., Durand J.C., Clough K.B. Breast cancers with central localization: conservative treatment by tumorectomy with ablation of the areolar plaque. Presse Med. 26:1997;988-994.
44. Neuschatz A.C., DiPetrillo T., Steinhoff M., Safaii H., Yunes M., Landa M., et al. The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast. Cancer. 94:2002;1917-1924.
45. Nos C., Fitoussi A., Bourgeois D., Fourquet A., Salmon R.J., Clough K.B. Conservative treatment of lower pole breast cancers by bilateral mammoplasty and radiotherapy. Eur J Surg Oncol. 24:1998;508-514.
46. Nos C., Bourgeois D., Freneaux P., Zafrani B., Salmon R.J., Clough K.B. Identification of sentinel lymph node in breast cancer: experience from the Institut Curie. Bull Cancer. 86:1999;580-584.
47. Nos C., Freneaux P., Louis-Sylvestre C., Hurren J.S., Heitz D., Sastre-Garau X., et al. Macroscopic quality control improves the reliability of blue dye-only sentinel lymph node biopsy in breast cancer. Ann Surg Oncol. 10:2003;525-530.
48. Ohtake T., Kimijima I., Fukushima T., Yasuda M., Sekikawa K., Takenoshita S., et al. Computer-assisted complete three-dimensional reconstruction of the mammary ductal/lobular systems: implications of ductal anastomoses for breast-conserving surgery. Cancer. 91:2001;2263-2272.
49. Pfleiderer S.O., Freesmeyer M.G., Marx C., Kuhne-Heid R., Schneider A., Kaiser W.A. Cryotherapy of breast cancer under ultrasound guidance: initial results and limitations. Eur Radiol. 12:2002;3009-3014.
50. Rambert P., Lasry S., Hennebelle F., Des Guetz G., Zhu D., Gentile A., et al. Local recurrence after conservative therapy of breast cancer: risk factors, site of recurrence, evolution. Bull Cancer. 81:1994;616-624.
51. Recht A., van Dongen J.A., Peterse J.L. Ductal carcinoma in situ. Lancet. 343:1994;969.
52. Roumen R.M., Kuijt G.P., Liem I.H., van Beek M.W. Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection. Br J Surg. 88:2001;1639-1643.
53. Salmon R.J., Bouillet T.H., Lewis J.S., Clough K.B. Recurrence in the axilla after sentinel lymph node biopsy for breast cancer. Eur J Surg Oncol. 28:2002;199.
54. Schnitt S.J., Abner A., Gelman R., Connolly J.L., Recht A., Duda R.B., et al. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer. 74:1994;1746-1751.
55. Scholl S.M., Asselain B., Palangie T., Dorval T., Jouve M., Garcia Giralt E., et al. Neoadjuvant chemotherapy in operable breast cancer. Eur J Cancer. 27:1991;1668-1671.
56. Scholl S.M., Fourquet A., Asselain B., Pierga J.Y., Vilcoq J.R., Durand J.C., et al. Neoadjuvant vs adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6. Eur J Cancer. 30:1994;645-652.
57. Schwartzberg B.S., Goates J.J., Keeler S.A., Moore J.A. Use of advanced breast biopsy instrumentation while performing stereotactic breast biopsies: review of 150 consecutive biopsies. J Am Coll Surg. 191:2000;9-15.
58. Sigal-Zafrani B., Lewis J., Clough K., Vincent-Salomon A., Fourquet A., Meunier M., et al. Histological margin assessment for breast ductal carcinoma in situ: precision and implications. Modern Pathology. 2003;. (sous presse).
59. Silverstein M.J., Lagios M.D., Craig P.H., Waisman J.R., Lewinsky B.S., Colburn W.J., et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer. 77:1996;2267-2274.
60. Singlebarry S.E., Fornage B.D., Sneige N., Ross M.I., et al. Radiofrequency ablation of early-stage invasive breast tumors: an overview. Cancer J. 8:2002;177-180.
61. Slotman B.J., Meyer O.W., Njo K.H., Karim A.B. Importance of timing of radiotherapy in breast conserving treatment for early stage breast cancer. Radiother Oncol. 30:1994;206-212.
62. Solin L.J., Fowble B.L., Schultz D.J., Goodman R.L. The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer. Int J Radiat Oncol Biol Phys. 21:1991;279-287.
63. Vaidya J.S., Hall-Craggs M., Baum M., Tobias J.S., Falzon M., D'Souza D.P., et al. Percutaneous minimally invasive stereotactic primary radiotherapy for breast cancer. Lancet Oncol. 3:2002;252-253.
64. Van Dongen J.A., Bartelink H., Fentiman I.S., Lerut T., Mignolet F., Olthuis G., et al. Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer. 28:1992;801-805.
65. Veronesi U., Banfi A., Salvadori B., Luini A., Saccozzi R., Zucali R., et al. Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trial. Eur J Cancer. 26:1990;668-670.
66. Voogd A.C., Nielsen M., Peterse J.L., Blichert-Toft M., Bartelink H., Overgaard M., et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol. 19:2001;1688-1697.
67. Zafrani B., Vielh P., Fourquet A., Mosseri V., Durand J.C., Salmon R.J., et al. Conservative treatment of early breast cancer: prognostic value of the ductal in situ component and other pathological variables on local control and survival. Long-term results. Eur J Cancer Clin Oncol. 25:1989;1645-1650.